Abstract
No public abstract is available from the verified source records.
Eric M. Davis, Sima K. Ramratnam, Jonathan E. Spahr
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Updated clinical classification of pulmonary hypertension
10.1016/j.jacc.2009.04.012 · 2009
Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology
10.1097/md.0b013e31818193bb · 2008
Zur histologie der klinischen 'primaren pulmonalsklerose'
1934
Pulmonary veno-occlusive disease
10.1164/ajrccm.162.5.9912045 · 2000
Pulmonary veno-occlusive disease: recent progress and current challenges
10.1016/j.rmed.2010.03.014 · 2010
Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease
10.2214/ajr.183.1.1830065 · 2004
Pulmonary veno-occlusive disease
10.1183/09031936.00090608 · 2009
Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease
10.1378/chest.113.1.237 · 1998
One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease
10.1590/s0100-879x2005000200006 · 2005
Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil
10.1136/thx.2007.088831 · 2008
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease
10.1183/09031936.00017809 · 2009
No additional external references are available.